Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia

Abstract Unfractionated heparin and low-molecular-weight heparin are currently the anticoagulants of choice for the prevention of recurrent thromboembolic disease during pregnancy. However, heparin-induced thrombocytopenia contraindicates the use of unfractionated heparin and low-molecular-weight he...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of obstetric anesthesia Vol. 19; no. 1; pp. 82 - 87
Main Authors:	Ekbatani, A, Asaro, L.R, Malinow, A.M
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Ltd 01-01-2010
Subjects:	Adult Anesthesia & Perioperative Care Anesthesia, Epidural Anesthesia, Obstetrical Anesthesia, Spinal Anticoagulants - adverse effects Anticoagulants - therapeutic use Anticoagulation Argatroban Female Heparin - adverse effects Heparin-induced thrombocytopenia Humans Obstetric Obstetrics and Gynecology Pipecolic Acids - therapeutic use Platelet Aggregation Inhibitors - therapeutic use Polysaccharides - therapeutic use Pregnancy Thrombocytopenia - blood Thrombocytopenia - chemically induced Thrombocytopenia - complications Thromboembolism Argatroban Anticoagulation Obstetric Thromboembolism Heparin-induced thrombocytopenia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!